ReviewAdvances in ophthalmology practice and research
Development and material characteristics of glaucoma surgical implants.
Review in Advances in ophthalmology practice and research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 18 citations in OpenAlex.
- The Duke Baerveldt 350 Versus Ahmed ClearPath 350 Study (DBACS): A Randomized Control Trial In Adults With Medically Refractory Glaucoma.Clinical ophthalmology (Auckland, N.Z.) · 2025Trial
- Corneal tomography and endothelial cell density after Paul glaucoma implant surgery.Acta ophthalmologica · 2026Article
- Two-year efficacy and safety outcomes of the Paul Glaucoma Implant compared to the Ahmed Glaucoma Valve.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Exchange of Ahmed glaucoma valve for a Paul glaucoma implant and management of postoperative hypotony: a case report.International journal of surgery case reports · 2026Article
- Hypertensive phase after a novel small-lumen non-valved drainage device: predictive factors and two-year outcomes.Japanese journal of ophthalmology · 2026Article
- A Biocompatible, Magnetic-Responsive Shape Memory Silicone Composite for Active Flow Controlling Valve.Advanced healthcare materials · 2025Article
- Article
- Efficacy and safety outcomes of the Paul glaucoma implant compared to the Ahmed glaucoma valve.Scientific reports · 2025Article
- Scleral tunneling combined with the Tenon's capsule coverage in Glaucoma Drainage Valve surgery.BMC ophthalmology · 2025Article
- Tube Flow Shunt: An Innovative and Cost-Effective Approach to the Modified Bleb-Forming Filtration Technique.Cureus · 2025Article
- Management of fracture and displacement of a previously successful bilateral transconjunctival ab-externo XEN gel stent: a case report.BMC ophthalmology · 2025Article
- In Vitro Analysis of Pressure Resistance in the Paul Glaucoma Implant and Ahmed ClearPath 250 With and Without Polypropylene Thread Inside the Tube.Translational vision science & technology · 2025Article
- Clinical outcomes and safety profile of glaucoma drainage device Ahmed ClearPath® 250 mmInternational journal of ophthalmology · 2025Article
- γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application.Drug delivery · 2024Article
- Efficacy and safety of the paul glaucoma implant in the treatment of refractory primary congenital glaucoma.Japanese journal of ophthalmology · 2024Article
- Paul Glaucoma Implant following Congenital Cataract Surgery in a Pediatric Cohort.Journal of clinical medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glaucoma is the leading cause of irreversible blindness worldwide. The reduction of intraocular pressure has proved to be the only factor which can be modified in the treatment, and surgical management is one of the important methods for the treatment of glaucoma patients. Main text: In order to increase aqueous humor outflow and further reduce intraocular pressure, various drainage implants have been designed and applied in clinical practice. From initial Molteno, Baerveldt and Ahmed glaucoma implants to the Ahmed ClearPath device, Paul glaucoma implant, EX-PRESS and the eyeWatch implant, to iStent, Hydrus, XEN, PreserFlo, Cypass, SOLX Gold Shunt, etc., glaucoma surgical implants are currently undergoing a massive transformation on their structures and performances. Multitudinous materials have been used to produce these implants, from original silicone and porous polyethylene, to gelatin, stainless steel, SIBS, titanium, nitinol and even 24-carat gold. Moreover, the material geometry, size, rigidity, biocompatibility and mechanism (valved versus nonvalved) among these implants are markedly different. In this review, we discussed the development and material characteristics of both conventional glaucoma drainage devices and more recent implants, such as the eyeWatch and the new minimally invasive glaucoma surgery (MIGS) devices. Conclusions: Although different in design and materials, these delicate glaucoma surgical implants have widely expanded the glaucoma surgical methods, and improved the success rate and safety of glaucoma surgery significantly. However, all of these glaucoma surgical implants have various limitations and should be used for different glaucoma patients at different conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.